Soluble fibrinogen-like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function

Soluble fibrinogen-like protein 2 (sFGL2), as a novel effector of regulatory T cells (Tregs), exhibits immune regulatory activity in several inflammatory diseases. Immune activation and persistent inflammation participate in the progression of ischemic heart failure (IHF). The present study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Ya, Huang, Shiyuan, Liu, Hui, Fan, Cheng, Liu, Kun, Wang, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188637/
https://www.ncbi.nlm.nih.gov/pubmed/34109427
http://dx.doi.org/10.3892/mmr.2021.12198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188637/
https://www.ncbi.nlm.nih.gov/pubmed/34109427
http://dx.doi.org/10.3892/mmr.2021.12198

Ejemplares similares